Document:

Exhibit
10.7

 

PRIVATE
PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [       ], 2022 (as it may from time
to time be amended, this “Agreement”), is entered into by and between Nubia Brand International Corp., a Delaware corporation
(the “Company”), and Mach FM Acquisitions LLC, a Delaware limited liability company (the “Purchaser”).

 

WHEREAS,
the Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit
consisting of one share of the Company’s Class A common stock, par value $0.0001 per share (a “Share”), and one-half
of one redeemable warrant, with each whole warrant exercisable for one Share at an exercise price of $11.50 per Share, as set forth in
the Company’s registration statement on Form S-1 related to the Public Offering filed with the U.S. Securities and Exchange Commission
(the “SEC”) (File No. 333-[_]) (the “Registration Statement”); and

 

WHEREAS, the Purchaser has agreed to purchase from the Company an aggregate
of 4,200,000 placement warrants at a price of $1.00 per warrant (the “Firm Sponsor Warrants”) (or up to 4,575,000 warrants
if the over-allotment option in connection with the Public Offering is exercised in full) (the “Additional Sponsor Warrants”
and, together with the Firm Sponsor Warrants, the “Sponsor Warrants”), each Sponsor Warrant entitling the holder to purchase
one Share at an exercise price of $11.50 per Share.

 

NOW
THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section
1. Authorization, Purchase and Sale; Terms of the Sponsor Warrants.

 

A.
Authorization of the Sponsor Warrants. The Company has duly authorized the issuance and sale of the Sponsor Warrants to the Purchaser.

 

B.
Purchase and Sale of the Sponsor Warrants.

 

(i) As payment in full for the 4,200,000 Firm Sponsor Warrants being purchased
under this Agreement, Purchaser shall pay an aggregate purchase price of $4,200,000 (the “Purchase Price”), by wire transfer
of immediately available funds or by such other method as may be reasonably acceptable to the Company, to the trust account (the “Trust
Account”) at a financial institution to be chosen by the Company, maintained by Continental Stock Transfer & Trust Company,
acting as trustee, at least one (1) business day prior to the date of effectiveness of the Registration Statement.

 

(ii) In
the event that the over-allotment option is exercised in full or in part, Purchaser shall purchase up to an additional 300,000 Additional
Sponsor Warrants, in the same proportion as the amount of the over-allotment option that is exercised, and simultaneously with such purchase
of Additional Sponsor Warrants, as payment in full for the Additional Sponsor Warrants being purchased hereunder, and at least one (1)
business day prior to the closing of all or any portion of the over-allotment option, Purchaser shall pay $1.00 per Additional Sponsor
Warrant, up to an aggregate amount of $300,000, by wire transfer of immediately available funds or by such other method as may be reasonably
acceptable to the Company, to the Trust Account.

 

(iii) The
closing of the purchase and sale of the Firm Sponsor Warrants shall take place simultaneously with the closing of the Public Offering
(the “Initial Closing Date”). The closing of the purchase and sale of the Additional Sponsor Warrants, if applicable, shall
take place simultaneously with the closing of all or any portion of the over-allotment option exercise (such closing date, together with
the Initial Closing Date, the “Closing Dates” and each, a “Closing Date”). The closing of the purchase and sale
of each of the Sponsor Warrants and the Additional Sponsor Warrants shall take place at the offices of Loeb & Loeb LLP, 345 Park
Avenue, New York, NY 10154, or such other place as may be agreed upon by the parties hereto.

 

     

     

    

 

C.
Terms of the Sponsor Warrants.

 

(i)
The Sponsor Warrants shall have their terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in
connection with the Public Offering (a “Warrant Agreement”).

 

(ii) At
or prior to the time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the
“Registration Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating
to the Sponsor Warrants and the Shares underlying the Sponsor Warrants.

 

Section
2. Representations and Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase
the Sponsor Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive
the Closing Dates) that:

 

A.
Organization and Corporate Power. The Company is a corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably
be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses
all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement, the Registration
Rights Agreement and the Warrant Agreement.

 

B.
Authorization; No Breach.

 

(i)
The execution, delivery and performance of this Agreement, the Registration Rights Agreement, the Warrant Agreement and the Sponsor Warrants
have been duly authorized by the Company as of the Closing Dates. Each of this Agreement, the Registration Rights Agreement and the Warrant
Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with its terms. Upon issuance in accordance
with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Sponsor Warrants will constitute valid and
binding obligations of the Company, enforceable in accordance with their terms as of the Closing Dates, as the case may be.

 

(ii) The
execution and delivery by the Company of this Agreement, the Registration Rights Agreement, the Warrant Agreement and the Sponsor Warrants,
the issuance and sale of the Sponsor Warrants, the issuance of the Shares upon exercise of the Sponsor Warrants and the fulfillment of,
and compliance with, the respective terms hereof and thereof by the Company, do not and will not as of the Closing Dates (a) conflict
with or result in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any
lien, security interest, charge or encumbrance upon the Company’s capital stock or assets under, (d) result in a violation of,
or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court
or administrative or governmental body or agency pursuant to the certificate of incorporation or the bylaws of the Company (in effect
on the date hereof or as may be amended prior to completion of the contemplated Public Offering), or any material law, statute, rule
or regulation to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject, except for
any filings required after the date hereof under federal or state securities laws.

 

C.
Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the
Shares issuable upon exercise of the Sponsor Warrants will be duly and validly issued, fully paid and nonassessable. Upon issuance in
accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title to the Sponsor
Warrants and the Shares issuable upon exercise of such Sponsor Warrants, free and clear of all liens, claims and encumbrances of any
kind, other than (i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under
federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

D.
Governmental Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority
is required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company
of any other transactions contemplated hereby.

 

    2 

     

    

 

Section
3. Representations and Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue
and sell the Sponsor Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and
warranties shall survive the Closing Dates) that:

 

A.
Organization and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.

 

B.
Authorization; No Breach.

 

(i)
This Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The
execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of the Closing Dates conflict with or result in a breach by the Purchaser of the terms, conditions or provisions
of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.

 

C.
Investment Representations.

 

(i)
The Purchaser is acquiring the Sponsor Warrants and, upon exercise of the Sponsor Warrants, the Shares issuable upon such exercise (collectively,
the “Securities”), for the Purchaser’s own account, for investment purposes only and not with a view towards, or for
resale in connection with, any public sale or distribution thereof.

 

(ii) The
Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D. under the Securities Act
of 1933, as amended (the “Securities Act”) and the Purchaser has not experienced a disqualifying event as enumerated pursuant
to Rule 506(d) of Regulation D under the Securities Act.

 

(iii) The
Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and
the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The
Purchaser did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule
502(c) of Regulation D under the Securities Act.

 

(v) The
Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

(vi)
The Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on
or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by
the Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

    3 

     

    

 

(vii) The
Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance
on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any
other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with
the terms and conditions of any exemption thereunder. In this regard, the Purchaser understands that the Securities and Exchange Commission
has taken the position that promoters or affiliates of a blank check company and their transferees, both before and after an initial
business combination, are deemed to be “underwriters” under the Securities Act when reselling the securities of a blank check
company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not be available for resale transactions of the
Securities despite technical compliance with the certain requirements of such Rule, and the Securities can be resold only through a registered
offering or in reliance upon another exemption from the registration requirements of the Securities Act.

 

(viii) The
Purchaser has such knowledge and experience in financial and business matters, knowledge of the high degree of risk associated with investments
in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment
in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have
no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can
afford a complete loss of its investments in the Securities.

 

Section
4. Conditions of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Sponsor Warrants
are subject to the fulfillment, on or before the Closing Dates, of each of the following conditions:

 

A.
Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct
at and as of the Closing Dates as though then made.

 

B.
Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by it on or before the Closing Dates.

 

C.
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization
having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this
Agreement or the Warrant Agreement.

 

D.
Warrant Agreement. The Company shall have entered into a Warrant Agreement with a warrant agent on terms set forth in the Registration
Statement and satisfactory to the Purchaser.

 

Section
5. Conditions of the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are subject
to the fulfillment, on or before the Closing Dates, of each of the following conditions:

 

A.
Representations and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct
at and as of the Closing Dates as though then made.

 

B.
Performance. The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this
Agreement that are required to be performed or complied with by the Purchaser on or before the Closing Dates.

 

C.
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization
having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this
Agreement or the Warrant Agreement.

 

    4 

     

    

 

D. Warrant
Agreement and Registration Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration
Rights Agreement on terms set forth in the Registration Statement.

 

Section
6. Termination. This Agreement may be terminated at any time after [_], 2022 upon the election by either the Company or a
Purchaser entitled to purchase a majority of the Sponsor Warrants upon written notice to the other parties if the closing of the
Public Offering does not occur prior to such date.

 

Section
7. Survival of Representations and Warranties. All of the representations and warranties contained herein shall survive the Closing
Dates.

 

Section
8. Definitions. Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the Registration
Statement on Form S-1 the Company has filed with the Securities and Exchange Commission.

 

Section
9. Miscellaneous.

 

A.
Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement
by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether
so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other
than assignments by the Purchaser to affiliates thereof.

 

B.
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision
shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C.
Counterparts. This Agreement may be executed simultaneously in two or more counterparts, none of which need to contain the signatures
of more than one party, but all such counterparts taken together shall constitute one and the same agreement.

 

D.
Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not
constitute a substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example
rather than by limitation.

 

E.
Governing Law. This Agreement shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes
shall be construed in accordance with the internal laws of the State of Delaware.

 

F. Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument
executed by all parties hereto.

 

[Signature
page follows]

 

    5 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	NUBIA
    BRAND INTERNATIONAL CORP.
	 	 
	 	By:	 
	 	Name:	Jaymes
    Winters
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	PURCHASER:
	 	 
	 	MACH
    FM ACQUISITIONS LLC
	 	 
	 	By:	
	 	Name:	
	 	Title:	Managing
    Member

 

Signature
Page to Private Placement

Warrants Purchase Agreementdynt_ex101.htm

  EXHIBIT 10.1
  
 
  
  
 January 10, 2022
  
 Mr. Brian Baker
 Hand-delivered
  
 RE:      Employment Offer – Chief Operating Officer
  
 Dear Brian:
  
 On behalf of Bird & Cronin, LLC and its parent company, Dynatronics Corporation, and its affiliate Hausmann Enterprises, LLC (collectively “Dynatronics”) I am pleased to offer you the position of Chief Operating Officer. Your proven qualifications and experience qualify you to receive this offer:
  
 	 Position/Title: 
	 Chief Operating Officer – classified as an exempt position under the Fair Labor Standards Act. You will not be eligible for overtime pay.

	  
	  

	  
	 You will report directly to the Chief Executive Officer.

	  
	  

	 Employer:
	 Your employer will be Bird & Cronin, LLC (“Employer”) and you will be eligible for Dynatronics benefits as described below.

	  
	  

	 Pay Rate: 
	 Starting salary will be $250,000.00 USD a year, paid $9,615.38 bi-weekly (every other Friday) paid via direct deposit by Employer.

	  
	  

	 Annual Bonus: 
	 Starting with Dynatronics Fiscal Year 2022 (July 1, 2021 – June 30, 2022), you will be eligible for an annual cash bonus, pro rata, for a targeted payout of $43,500 (17.5% of base salary) cash USD. The cash bonus will be based on Dynatronics results and successful completion of individual performance against set goals. You must be employed on the date the bonus is paid in order to be eligible. The Compensation Committee of the Board of Directors will assess the goals to determine annual payout. Bonuses, if approved, are generally paid in September following a plan year. 

	  
	  

	 Annual Equity Award: 
	 You will be eligible for an annual equity award, pro rata, of Restricted Stock Units (“RSUs”) up to a targeted value of $43,500 (17.5% of base salary). The RSUs will be priced at the closing market share price of Dynatronics common stock on the date of the grant. Fifty percent (50%) of the RSUs will vest on the date of the grant and fifty percent (50%) of the RSUs will vest on the first anniversary date of the grant. The annual equity award will be based on Dynatronics results and the successful completion of individual performance against set goals. The Compensation Committee of the Board of Directors will assess the goals to determine annual award. Bonuses, if approved, are generally paid in September following a plan year.

	  
	  

	 Responsibilities: 
	 The following duties of this position are intended to be illustrative and not inclusive:

   
 	  
	 •
	 Formulates long and short-term strategies, organization structure, policies, programs, processes, and objectives that support the organization in achievement of goals.

	  
	  
	  

	  
	 •
	 Develops the operations strategy and objectives to ensure that products conform to established customer and company quality standards and expectations.

	  
	  
	  

	  
	 •
	 Leads the integrated business Sales and Operational Planning process for company including demand and supply planning, procurement and distribution execution and financial reconciliation of inventory plans.

   
 	 
	 1

	

	 

  
 
  
  
 	  
	 •
	 Owns global purchasing, reporting, usages and stock replenishment processes. Identifies and resolves issues and ensures supply chain effectiveness.

	  
	  
	  

	  
	 •
	 Establishes and maintains metrics for the department including forecast and delivery accuracy, inventory, warehouse and supplier performance and other data leading to identification and implementation of improvements.

	  
	  
	  

	  
	 •
	 Ensures product integrity and regulatory compliance through partnership with RA/QA operations and conformance to company Quality Management System in accordance with FDA Quality System Regulations and ISO 13485 guidelines.

	  
	  
	  

	  
	 •
	 Maintains GMP compliant warehouse/distribution locations to ensure proper material flow, cleanliness, receiving, warehousing and distribution. Ensures robust and QMS compliant supply chain for company product.

	  
	  
	  

	  
	 •
	 Provides leadership that maximizes employee talents, promotes a high-performance work environment, and demonstrates consistent performance management including mentoring, coaching, and career development practices.

	  
	  
	  

	  
	 •
	 Selects, develops, manages and continuously recalibrates of staff.

	  
	  
	  

	  
	 •
	 Plays a lead role in the diligence process for future acquisitions. Drives the integration of acquisitions into Dynatronics by implementing the company processes and policies into the acquired company.

	  
	  
	  

	  
	 •
	 Drives a culture of continuous improvement through the organization. Identifies and implements metrics to measure operational performance and to hold the entire organization accountable to achieve our key results.

	  
	  
	  

	  
	 •
	 Perform additional, related duties as needed

   
 	 Benefits: 
	 In addition to your compensation, you will be eligible to receive additional benefits which are offered by Dynatronics. Benefit eligibility begins on the 1st of the month following hire date. The Dynatronics benefits are described in detail in the employee Benefits Guide with the current 401(k) and PTO policies summarized below.

	  
	  

	  
	 Paid Time Off: You will be eligible for Dynatronics’ unlimited, flexible Paid Time Off (PTO) policy, which does not prescribe vacation/sick days or a set PTO accrual. You will simply continue to receive your regular pay when taking time away from work for vacation or other personal reasons. However, extended leaves of absences (e.g., medical leave under FMLA) are excluded and will need to be separately negotiated.

	  
	  

	  
	 401(k)
 You will be eligible for Dynatronics 401(k) retirement program administered by Fidelity Investments. You will become eligible to participate in this program on the 1st of the month following hire date. You will be eligible for a match of 50% of your contributions, up to a maximum of 6% of eligible compensation and caps at $3,000 annually. The Employer’s contributions vest over a 6-year period (Year 1: 10%, Year 2: 20%, Year 3: 40%, ..., Year 6: 100%).

	  
	  

	 Expenses: 
	 Your Employer will promptly reimburse you for all reasonable business expenses incurred by you in performing your duties.

	  
	  

	 Code of Ethics:
	 Your Employer and Dynatronics are committed to maintaining the highest ethical standards and to conducting business with the highest level of integrity. Employees are required to adhere to all policies, including its Code of Business Ethics and uphold an uncompromising standard of conduct, honesty, integrity, and ethics in dealing with each other and with customers, regulators, vendors, and all other third parties. In addition to personally complying with the Code of Business Ethics, employees have a responsibility to report any violations of such policy. Failure to abide by this Code or report any violation will result in disciplinary action, up to and including termination of employment.

  
 	 
	 2

	

	 

 
  
  
 	 Other Employment: 
	 During the term of your employment you may not engage in secondary employment or consulting services without advanced written permission from Dynatronics President and Chief Executive Officer, whose permission may be withheld for any reason.

	  
	  

	 Non-compete:
	 As a condition of employment, you will be required to sign a confidentiality agreement and non-compete agreement that will limit your ability to be employed by a competitor of Dynatronics for a 12-month period following your termination. 

	  
	  

	 Prior Covenants: 
	 You represent that you are not party to any restrictive covenant from prior employment limiting your ability to perform the duties described in this offer of employment and that accepting this offer of employment will not knowingly violate any restrictive covenant imposed on you by a prior employer. You and Dynatronics agree that Dynatronics has no interest in any information you may have that is deemed proprietary or confidential under any restrictive covenants with any prior employer or other third party. You will not divulge such information, directly or indirectly, to Dynatronics. You will not use or disclose proprietary or confidential information or trade secrets of any former employer or other person or other entity with which you have any agreement or duty of confidentiality. 

	  
	  

	 At will: 
	 As an at-will employer, your Employer reserves the right to terminate any employee at any time for any reason or for no reason at all. It should be understood that this offer of employment is not a contract nor is it a guarantee of employment for any specific period of time. This provision is subject to the laws of the state in which you live.

	  
	  

	 Start Date:
	 Once you have accepted our offer, we would like your official employment start date to be no later than January 17, 2022.  This date is negotiable, depending on your availability.  

   
 We are genuinely excited about adding you to our team. We look forward to hearing back from you by the end of business on January 14, 2022 in order to facilitate sufficient time for background check and drug screen results.
  
 By signing below, I acknowledge I have received the foregoing information regarding my employment offer and related pay and benefits provided in accordance with Minnesota Statutes sec. 181.032. I understand that Bird & Cronin, LLC and its parent company, Dynatronics Corporation, employment is not for a specific term and can be terminated by the company at any time for any reason, with or without cause. Notices will be available in translated forms. Please contact our office at 651-683-1111 to request a particular language. 
  
 Sincerely,
  
 John Krier
  
 John Krier
 Chief Executive Officer
  
 Understood and Accepted as of January 17, 2022:
  
 Signed: /s/ Brian Baker                        
               Brian Baker
  
 	 
	 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]